| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $199,260,628 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR075726 | Voltage sensor domain movements in skeletal muscle fiber activation | 001 | 5 | NIH | 5/22/2025 | $23,793 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073136 | Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | 000 | 4 | NIH | 3/7/2025 | $458,677 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR075726 | Voltage sensor domain movements in skeletal muscle fiber activation | 000 | 5 | NIH | 2/18/2025 | $305,910 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DA041117 | 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | 000 | 11 | NIH | 3/13/2025 | $1,677,585 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG076441 | Recovery among Older Adults Following Head Injury | 001 | 4 | NIH | 6/9/2025 | $53,414 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DA041117 | 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | 002 | 11 | NIH | 9/19/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG076441 | Recovery among Older Adults Following Head Injury | 000 | 4 | NIH | 3/7/2025 | $600,915 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K23AI189218 | The Role of Gender-Affirming Hormone Therapy in Anal Human Papilloma Virus Persistence (HPV) and Systemic and Mucosal Immunity in Transgender Women with and without HIV | 000 | 1 | NIH | 9/12/2025 | $140,740 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 007 | 3 | NIH | 9/17/2025 | $49,384 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 006 | 3 | NIH | 9/15/2025 | $121,550 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 005 | 3 | NIH | 9/12/2025 | $110,636 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL181475 | Cell type-specific roles of integrin CD11b in atherosclerosis regression | 000 | 1 | NIH | 8/18/2025 | $752,709 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 008 | 3 | NIH | 9/18/2025 | $167,709 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $110,636 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 009 | 3 | NIH | 9/18/2025 | $104,981 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $66,666 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $150,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $333,458 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R56DA064273 | Combining Experiments, Simulations, and AI to Interrogate the Pharmacology of Fentanyl and Nitazene Derivatives | 000 | 1 | NIH | 8/21/2025 | $428,432 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32GM159581 | Training Program in Cellular and Molecular Membrane Biology | 000 | 1 | NIH | 8/18/2025 | $416,240 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011804 | Strengthening Capacity in Health Research Ethics and Methodology in The Gambia | 000 | 4 | NIH | 3/12/2025 | $237,788 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 001 | 2 | NIH | 8/5/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL139613 | Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension | 002 | 7 | NIH | 4/25/2025 | $519,022 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 000 | 2 | NIH | 3/6/2025 | $39,221 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL139613 | Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension | 003 | 7 | NIH | 6/3/2025 | $57,669 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03AG095718 | Association of Peripheral Nerve Blocks with Postoperative Outcomes and Readmissions in Older Adults Undergoing Hip Fracture Surgery | 000 | 1 | NIH | 8/7/2025 | $388,750 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K24DA061154 | Effects of prenatal and postnatal cannabis use on Lactation And Maternal Bonding (LAMB) | 000 | 1 | NIH | 7/11/2025 | $171,822 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120929 | Image-guided, intra-arterial delivery of antibodies to the central nervous system | 001 | 5 | NIH | 8/5/2025 | $38,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120929 | Image-guided, intra-arterial delivery of antibodies to the central nervous system | 000 | 5 | NIH | 3/4/2025 | $347,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032225 | The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | 002 | 3 | NIH | 8/6/2025 | $255,985 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 000 | 10 | NIH | 3/4/2025 | $566,653 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA063090 | Joint decomposition of SCORCH mulit-omic data to explore the impact of SUD and HIV on reward circuitry and neuroinflammation | 000 | 1 | NIH | 8/25/2025 | $556,432 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032225 | The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | 002 | 3 | NIH | 8/6/2025 | $215,441 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 002 | 10 | NIH | 9/18/2025 | $99,998 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33HL168723 | Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma. | 000 | 3 | NIH | 8/26/2025 | $361,930 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 001 | 10 | NIH | 7/11/2025 | $60,205 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | RF1MH134721 | A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men | 000 | 3 | NIH | 8/26/2025 | $2,187,174 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS143338 | Exploring the Subthalamic Nucleus Role in Variability Regulation | 001 | 1 | NIH | 8/4/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS143338 | Exploring the Subthalamic Nucleus Role in Variability Regulation | 000 | 1 | NIH | 8/4/2025 | $42,464 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | S15OD039775 | Helium Recovery System | 000 | 1 | NIH | 8/11/2025 | $349,500 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK140281 | Periodontitis Role in Inflammatory Bowel Disease | 000 | 1 | NIH | 8/28/2025 | $3,340,009 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA295603 | Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification | 000 | 1 | NIH | 8/22/2025 | $2,840,768 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI187788 | CD27-mediated immune suppression by HSPCs, innate immune cells or non-hematopoietic cells | 000 | 1 | NIH | 7/23/2025 | $427,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 001 | 2 | NIH | 5/29/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS117102 | Stem Cell Surface Modification to Promote Nerve Regeneration | 000 | 4 | NIH | 3/11/2025 | $272,722 |
|
